• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Second-generation drug-eluting stents versus bare-metal stents in saphenous vein grafts: is the choice more complicated than before?

作者信息

Pellicano Mariano, Azzano Alessia, Barbato Emanuele

机构信息

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.

出版信息

J Thorac Dis. 2019 Mar;11(Suppl 3):S385-S389. doi: 10.21037/jtd.2018.12.23.

DOI:10.21037/jtd.2018.12.23
PMID:30997227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6424759/
Abstract
摘要

相似文献

1
Second-generation drug-eluting stents versus bare-metal stents in saphenous vein grafts: is the choice more complicated than before?第二代药物洗脱支架与隐静脉移植物中的裸金属支架：选择是否比以前更复杂？
J Thorac Dis. 2019 Mar;11(Suppl 3):S385-S389. doi: 10.21037/jtd.2018.12.23.
2
Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.药物洗脱支架在静脉桥病变中的时间疗效。
J Am Coll Cardiol. 2018 May 8;71(18):1973-1982. doi: 10.1016/j.jacc.2018.03.456.
3
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.药物洗脱支架与金属裸支架治疗隐静脉桥病变的比较（ISAR-CABG）：一项随机对照优效性试验。
Lancet. 2011 Sep 17;378(9796):1071-8. doi: 10.1016/S0140-6736(11)61255-5. Epub 2011 Aug 26.
4
Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts.药物洗脱支架与金属裸支架置入在静脉桥中的长期安全性和疗效比较。
Circ Cardiovasc Interv. 2010 Jun 1;3(3):249-56. doi: 10.1161/CIRCINTERVENTIONS.109.929042. Epub 2010 May 4.
5
Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).西罗莫司洗脱支架与裸金属支架植入病变大隐静脉桥血管的血管内超声比较（来自RRISC[使用Cypher西罗莫司洗脱支架减少大隐静脉桥血管再狭窄]试验）
Am J Cardiol. 2007 Jul 1;100(1):52-8. doi: 10.1016/j.amjcard.2007.02.052. Epub 2007 May 11.
6
Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.在病变大隐静脉移植物中，西罗莫司洗脱支架与裸金属支架相比晚期死亡率增加：随机DELAYED RRISC试验的结果
J Am Coll Cardiol. 2007 Jul 17;50(3):261-7. doi: 10.1016/j.jacc.2007.05.010. Epub 2007 Jun 13.
7
Drug-eluting versus bare-metal stents for saphenous vein graft lesions.药物洗脱支架与金属裸支架治疗大隐静脉桥病变。
Intern Med J. 2019 Dec;49(12):1534-1537. doi: 10.1111/imj.14659.
8
Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.药物洗脱支架与金属裸支架在隐静脉桥血管介入治疗中的应用比较。
Circ Cardiovasc Interv. 2018 Nov;11(11):e007045. doi: 10.1161/CIRCINTERVENTIONS.118.007045.
9
Editorial: bare metal stents versus drug-eluting stents for saphenous vein grafts-an interventionalist's dilemma!
J Interv Cardiol. 2011 Apr;24(2):181-3. doi: 10.1111/j.1540-8183.2011.00641.x.
10
Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduits.第二代依维莫司洗脱支架与第一代药物洗脱支架治疗用于冠状动脉搭桥的大隐静脉狭窄的 2 年随访结果。
Am J Cardiol. 2013 Jul 1;112(1):61-7. doi: 10.1016/j.amjcard.2013.02.055. Epub 2013 Apr 2.

本文引用的文献

1
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.药物洗脱支架与金属裸支架在静脉桥中的应用：一项双盲、随机试验。
Lancet. 2018 May 19;391(10134):1997-2007. doi: 10.1016/S0140-6736(18)30801-8. Epub 2018 May 11.
2
Stents in saphenous vein grafts.隐静脉移植物中的支架
Lancet. 2018 May 19;391(10134):1967-1968. doi: 10.1016/S0140-6736(18)30937-1. Epub 2018 May 11.
3
Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.药物洗脱支架在静脉桥病变中的时间疗效。
J Am Coll Cardiol. 2018 May 8;71(18):1973-1982. doi: 10.1016/j.jacc.2018.03.456.
4
National Trends and Geographic Variation in Bilateral Internal Mammary Artery Use in the United States.美国双侧乳内动脉使用情况的全国趋势及地理差异
Ann Thorac Surg. 2017 Dec;104(6):1902-1907. doi: 10.1016/j.athoracsur.2017.08.055. Epub 2017 Nov 1.
5
Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.使用双侧乳内动脉移植与左侧乳内动脉移植的长期和短期结果：一项荟萃分析。
Heart. 2017 Sep;103(18):1419-1426. doi: 10.1136/heartjnl-2016-310864. Epub 2017 Jun 23.
6
Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.对于既往接受冠状动脉旁路移植术（CABG）的患者，在二次经皮冠状动脉介入治疗（PCI）后，使用自身血管进行PCI与使用移植血管进行PCI相比，长期预后更佳。
Int J Cardiol. 2017 Feb 1;228:563-569. doi: 10.1016/j.ijcard.2016.11.031. Epub 2016 Nov 14.
7
Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的应用：来自退伍军人事务部临床评估、报告和跟踪计划的见解。
JACC Cardiovasc Interv. 2016 May 9;9(9):884-93. doi: 10.1016/j.jcin.2016.01.034. Epub 2016 Apr 13.
8
Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.第一代与第二代药物洗脱支架治疗大隐静脉桥病变的长期预后
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):34-40. doi: 10.1002/ccd.25982. Epub 2015 May 29.
9
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.冠状动脉旁路移植手术后大隐静脉桥失败：来自 PREVENT IV 的研究结果。
Circulation. 2014 Oct 21;130(17):1445-51. doi: 10.1161/CIRCULATIONAHA.113.008193. Epub 2014 Sep 26.
10
Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts.经皮冠状动脉介入治疗中，西罗莫司洗脱支架与紫杉醇洗脱支架和依维莫司洗脱支架的长期比较。
EuroIntervention. 2014;9(12):1432-40. doi: 10.4244/EIJV9I12A241.